BRAVADAX Trademark

Trademark Overview


On Tuesday, November 10, 2015, a trademark application was filed for BRAVADAX with the United States Patent and Trademark Office. The USPTO has given the BRAVADAX trademark a serial number of 86815292. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 17, 2023. This trademark is owned by Sanofi. The BRAVADAX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-diabetic preparations
bravadax

General Information


Serial Number86815292
Word MarkBRAVADAX
Filing DateTuesday, November 10, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 17, 2023
Registration Number5034967
Registration DateTuesday, September 6, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements


Goods and ServicesAnti-diabetic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events


Event DateEvent Description
Friday, March 17, 2023CANCELLED SEC. 8 (6-YR)
Monday, September 6, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 6, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, May 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 28, 2016ASSIGNED TO LIE
Wednesday, April 13, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, December 8, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, December 8, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, December 8, 2015SUSPENSION LETTER WRITTEN
Tuesday, December 1, 2015ASSIGNED TO EXAMINER
Friday, November 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 13, 2015NEW APPLICATION ENTERED

Related Keywords


bravadax preparations diabetic anti